Secondary Parkinsonism
Links shared publicly online about this topic
Relief Sought for Secondary Parkinson's Symptoms - Drugs.com MedNews
drugs.com — “A new set of guidelines to treat sleepiness, constipation and sexual dysfunction in people with Parkinson s disease has been released by the American Academy of” View full resource at drugs.com
Most Recently Shared on March 15, 2010 at 10:04 pm By:
Relief Sought for Secondary Parkinson's Symptoms - http://bit.ly/cPm6cn
ACADIA Pharmaceuticals Announces Results From Phase III Trial Of Pimavanserin In Parkinson's Disease Psychosis
medicalnewstoday.com — “ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced top-line results from the first pivotal Phase III trial with pimavanserin in patients with Parkinson's disease psychosis, or PDP. The study did” View full resource at medicalnewstoday.com
Most Recently Shared on September 2, 2009 at 5:15 pm By:
MNT Parkinson's News Health News
ACADIA Pharmaceuticals Announces Results From Phase III Trial Of Pimavanserin In Parkinson's Disease Psychosis: .. http://bit.ly/jQIUV
How Should Parkinsonism Due to Drug Use Be Treated? - QualityPoint Technologies
qualitypointtech.net — “A psychiatric patient has parkinsonism secondary to long-term neuroleptic use. Which medications might minimize this symptom? USMLEasy from McGraw-Hill” View full resource at qualitypointtech.net
Most Recently Shared on March 3, 2011 at 5:35 pm By:
How Should Parkinsonism Due to Drug Use Be Treated?: A psychiatric patient has parkinsonism secondary to long-term... http://bit.ly/eAImGl
The Lancet Neurology : Volume 9, Number 6, 1 June 2010
thelancet.com — “The Lancet is the world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. Available online first. Free registration.” View full resource at thelancet.com
Most Recently Shared on May 20, 2010 at 9:07 am By:
Latest issue of The Lancet Neurology online now. http://bit.ly/d70rBU
AFFiRiS to commence Phase II trial of its Alzheimer's vaccine candidate
news-medical.net — “AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.” View full resource at news-medical.net
Most Recently Shared on November 21, 2009 at 4:09 am By:
Parkinson's Disease: AFFiRiS to commence Phase II trial of its Alzheimer's vaccine candidat.. http://bit.ly/42rWJA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MNT Parkinson's News
The latest parkinson's disease news published daily. Articles from research centers, universities and prestigious journals.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement
